← Open Payments lookup

TEODORO BORDADOR: Open Payments

NPI 1750358313 · SALEM, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,903 in 217 payments from 14 companies in 2025. Trend: 2023 $4,401 · 2024 $5,835 · 2025 $4,903

Food & beverage: $4,903
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$844
ABBVIE INC.35$637
E.R. Squibb & Sons, L.L.C.14$564
Neurocrine BioSciences, Inc.41$532
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$448
Supernus Pharmaceuticals, Inc.16$415
Otsuka America Pharmaceutical, Inc.23$338
Axsome Therapeutics, Inc.8$326
Alkermes, Inc.14$301
Vanda Pharmaceuticals Inc.8$255

Products named: VRAYLAR, COBENFY, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY, Qelbree, Auvelity.

Industry payments across IN — which companies pay providers there.